David D. Allison - Apr 8, 2022 Form 4/A - Amendment Insider Report for CinCor Pharma, Inc. (CINC)

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Apr 8, 2022
Transactions value $
$12,498
Form type
4/A - Amendment
Date filed
7/20/2022, 04:39 PM
Date Of Original Report
May 11, 2022
Previous filing
Jan 6, 2022
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $12.5K +1.04K $12.04 1.04K Apr 8, 2022 Common Stock 1.04K $19.55 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.
F2 This amendment to the Form 4 initially filed on May 11, 2022 is being made to clarify the purpose of the option grant set forth in footnote 1 above and the amount in director retainer fees foregone as set forth in box 8 above.